Osseointegrated implant failure associated with MMP-1 promotor polymorphisms (-1607 and -519)

International Journal of Oral and Maxillofacial Implants

Volumn 23, Issue 4, 2008, Pages 653-658

  Leite, Mayra F F ^a   Santos, Maria C L G ^a   De Souza, Ana P ^b   Line, Sergio R P ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b University of Sacred Heart (USC)   (Brazil)

Author keywords

Implant failure; MMP 1; Polymorphism

Indexed keywords

INTERSTITIAL COLLAGENASE;

ADULT; ALLELE; ARTICLE; BONE REGENERATION; CASE CONTROL STUDY; DENTAL SURGERY; FEMALE; GENE FREQUENCY; GENETIC MARKER; GENETICS; HUMAN; MALE; MISSENSE MUTATION; PROMOTER REGION; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; TOOTH IMPLANTATION;

ADULT; ALLELES; CASE-CONTROL STUDIES; DENTAL IMPLANTATION, ENDOSSEOUS; DENTAL RESTORATION FAILURE; FEMALE; GENE FREQUENCY; GENETIC MARKERS; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MUTATION, MISSENSE; OSSEOINTEGRATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RETROSPECTIVE STUDIES;

EID: 50849097036     PISSN: 08822786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Adell R, Eriksson B, Lekholm U, Brånemark P-I, Jemt T. Long-term follow-up study of osseointegrated implants in the treatment of totally edentulous jaws. Int J Oral Maxillofac Implants 1990;5:347-359.
2. Lekholm U, Gunne J, Henry P, et al. Survival of the Brånemark implant in partially edentulous jaws: A 0-10 year prospective multicenter study. Int J Oral Maxillofac Implants 1999;14:639-645.
3. Esposito M, Hirsch JM, Lekholm U, Thomsen P. Biological factors contributing to failures of osseointegrated oral implants. (I). Success criteria and epidemiology. Eur J Oral Sci 1998;106:527-551.
4. Thompson MW, McInnes RR, Willard, HF, Thompson & Thompson Genetics in Medicine, ed 5. Philadelphia: Saunders, 1991.
5. Kanamori Y, Matsushima M, Minaguchi T, et al. Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res 1999;59:4225-4227.
6. Peters DG, Kassam A, St Jean PL, Yonas H, Ferrell RE. Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm. Stroke 1999;30:2612-2616.
7. Lamblin N, Bauters C, Hermant X, Lablanche JM, Helbecque N, Amouyel P. Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease. J Am Coll Cardiol 2002;40:43-48.
8. Fujimoto T, Parry S, Urbanek M, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. J Biol Chem 2002;277:6296-6302.
9. De Souza AP, Trevilatto PC, Scarel-Caminaga RM, Brito RB Jr, Line SRP. MMP1 promoter polymorphism: Association with chronic periodontitis severity in a Brazilian population. J Clin Periodontol 2003;30:154-158.
10. Kerrigan JJ, Mansell JP, Sandy JR. Matrix turnover. J Orthod 2000;27:227-233.
11. Brikedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontol 1993;64:474-484.
12. Teronen O, Konttinen YT, Lindqvist C, et al. Human neutrophil collagenase MMP-8 in peri-implant sulcus fluid and its inhibition by clodronate. J Dent Res 1997;76:1529-1537.
13. Apse P, Ellen RP, Overall CM, Zarb GA. Microbiota and crevicular fluid collagenase activity in the osseointegrated dental implant sulcus: A comparison of sites in edentulous and partially edentulous patients. J Periodontal Res 1989;24:96-105.
14. Ingman T, Kononen M, Konttinen YT, Siirila HS, Suomalainen K, Sorsa T. Collagenase, gelatinase and elastase activities in sulcular fluid of osseointegrated implants and natural teeth. J Clin Periodontol 1994;21:301-307.
15. Ma J, Kitti U, Teronen O, et al. Collagenases in different categories of peri-implant vertical bone loss. J Dent Res 2000;79:1870-1873.
16. Golub LM, Lee HM, Greenwald RA, et al. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res 1997;46:310-319.
17. Yamada Y, Ando F, Niino N, Shimokata H. Association of a polymorphism of the matrix metalloproteinase-1 gene with bone mineral density. Matrix Biology. 2002;21:389-392.
18. Dunleavey L, Beyzade S, Ye S. Rapid genotype analysis of the matrix metalloproteinase-1 gene 1G/2G polymorphism that is associated with risk of cancer. Matrix Biol 2000;19:175-177.
19. Holliday LS, Welgus HG, Fliszar CJ, Veith GM, Jeffrey JJ, Gluck SL. Initiation of osteoclast bone resorption by interstitial collagenase. J Biol Chem 1997;272:22053-22058.
20. Brinckerhoff CE, Rutter JL, Benbow U. Interstitial collagenases as markers of tumor progression.Clin Cancer Res 2000;6:4823-4830.
21. Vincenti MP, White LA, Schroen DJ, Benbow U, Brinckerhoff CE. Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): Mechanisms that control enzyme activity, transcription, and mRNA stability. Crit Rev Eukaryot Gene Expr 1996;6:391-411.
22. Rutter JL, Mitchell TI, Buttice G, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 1998;58:5321-5325.
23. Nishioka Y, Kobayashi K, Sagae S, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas. J Cancer Res 2000;91:612-615.
24. Jurajda M, Muzik J, Izakovicova Holla L, Vacha J. A newly identified single nucleotide polymorphism in the promoter of the matrix metalloproteinase-1 gene. Mol Cell Probes 2002;16:63-66.
25. Trevilatto PC, Line SRP. Use of buccal epithelial cells for PCR amplification of large DNA fragments. J Forensic Odontostomatol 2000;18:6-9.
26. Esposito M, Hirsch JM, Lekholm U, et al. Biological factors contributing to failures of osseointegrated oral implants. (II). Etiopathogenesis.Eur J Oral Sci 1998;106:721-764.
27. Santos MCLG, Campos MIG, Line SRP. Early dental implant failure: review of the literature. Braz J Oral Sci 2002;1:103-111.
28. Herrmann I, Lekholm U, Holm S, Karlsson S. Impact of implant interdependency when evaluating success rates: A statistical analysis of multicenter results. Int J Prosthodont 1999;12:160-166.
29. Herrmann I, Lekholm U, Holm S, Kultje C. Evaluation of patient and implant characteristics as potential prognostic factors for oral implant failures. Int J Oral & Maxillofac Implants 2005;20:220-230.
30. Adell R, Lekholm U, Rockler B, et al. Marginal tissue reactions at osseointegrated titanium fixtures (I). A 3-year longitudinal prospective study. Int J Oral Maxillofac Surg 1986;15:39-52.
31. Lekholm U, Adell R, Lindhe J, et al. Marginal tissue reactions at osseointegrated titanium fixtures. (II). A cross-sectional retrospective study. Int J Oral Maxillofac Surg 1986;15:53-61.
32. Seymour GJ, Gemmell E, Lenz U, Henry P, Bower R, Yamazaki K. Immunohistologic analysis of the inflammatory infiltrates associated with osseointegrated implants. Int J Oral Maxillofac Implants 1989;4:191-198.
33. Salvi GE, Brown CE, Fujihashi K, et al. Inflammatory mediators of the terminal dentition in adult and early onset periodontitis. J Periodontal Res 1998;33:212-225.
34. Dongari-Bagtzoglou AI, Ebersole JL. Increased presence of interleukin-6 (IL-6) and IL-8 secreting fibroblast subpopulations in adult periodontitis. J Periodontol 1998;69:899-910.
35. Heath JK, Atkinson SJ, Hembry RM, Reynolds JJ, Meikle MC. Bacterial antigens induce collagenase and prostaglandin E2 synthesis in human gingival fibroblasts through a primary effect on circulating mononuclear cells. Infect Immun. 1987;55:2148-2154.
36. Aboyoussef H, Carter C, Jandinski JJ, Panagakos FS. Detection of prostaglandin E2 and matrix metalloproteinases in implant crevicular fluid. Int J Oral Maxillofac Implants 1998;13:689-696.
37. Greensteing G, Hart TC. A critical assessment of interleukin-1 (IL-I ) genotype when used in a genetic susceptibility test for severe chronic periodontitis. J Periodontol 2002;73:231-247.
38. Wilson TG Jr, Nunn M. The relationship between the interleukin-1 periodontal genotype and implant loss. Initial data. J Periodontol 1999;70:724-729.
39. Santos MCLG, Campos MIG, Souza AP, Scarel-Caminaga RM, Mazzonetto R, Line SRP. Analysis of the transforming growth factor-β1 gene promoter polymorphisms in early osseointegrated implant failure. Implant Dent 2004;13:262-269.
40. Campos MIG, Santos MCLG, Trevilatto PC, Scarel-Caminaga RM, Bezerra FJB, Line SRP. IL-2 and IL-6 gene promoter polymorphisms and early failure of dental implants. Implant Dent 2005;14:391-396.
41. Feloutzis A, Lang NP, Tonetti MS, et al. IL-1 gene polymorphism and smoking as risk factors for peri-implant bone loss in a well-maintained population. Clin Oral Implant Res 2003;14:10-17.
42. Astolfi CM, Shinohara AL, Silva RA, Santos MCLG, Line SRP, de Souza AP. Genetic polymorphism in the MMP-1 and MMP-3 gene may contribute to chronic periodontitis in a Brazilian population. J Clin Periodont (in press).
43. Putt W, Palmen J, Nicaud V, et al. Variation in USF1 shows haplotype effects, gene: Gene and gene: Environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II. Hum Mol Genet 2004;13:1587-1597.
44. Mannila MN, Eriksson P, Lundman P, et al. Contribution of haplotypes across the fibrinogen gene cluster to variation in risk of myocardial infarction. Thromb Haemost 2005;93:570-577.
45. Linne Y, Dahlman I, Hoffstedt J. Beta1-adrenoceptor gene polymorphism predicts long-term changes in body weight. Int J Obes Relat Metab Disord 2005;29:458-462.
46. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000;275:18138-18144.
47. Garner C, Slatkin M. On selecting markers for association studies: Patterns of linkage disequilibrium between two and three diallelic loci. Genet Epidemiol 2003;24:57-67.